Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma (2017) Kumar S, Moreau P, Hari P, Mateos MV, Ludwig H, Shustik C, Masszi T, et al. Journal article Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure (2017) Cybulska A, Meintker L, Ringwald J, Krause S Journal article Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group (2016) Cseh AM, Niemeyer CM, Yoshimi A, Catala A, Fruehwald MC, Hasle H, Van Den Heuvel-Eibrink MM, et al. Journal article Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma (2016) Hillengass J, Ritsch J, Merz M, Wagner B, Kunz C, Hielscher T, Laue H, et al. Journal article TP53 mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation (2016) Middeke JM, Herold S, Ruecker-Braun E, Berdel WE, Stelljes M, Kaufmann M, Schaefer-Eckart K, et al. Journal article DNA copy number alterations mark disease progression in paediatric chronic myeloid leukaemia (2014) Van Der Sligte NE, Krumbholz M, Pastorczak A, Scheijen B, Tauer JT, Nowasz C, Sonneveld E, et al. Journal article